Reducept, founded in 2018, is a pioneering company at the intersection of Digital Health and VR/AR industries, headquartered in The Netherlands. This innovative startup offers a revolutionary VR application aimed at treating chronic pain without medication. Their comprehensive approach integrates various scientifically backed techniques, ensuring effective, standardized, and on-demand treatment options.
Currently implemented across more than 250 practices and institutions, Reducept demonstrates significant impact, with clinical trials indicating that about 80% of patients experience notable reductions in pain. Besides direct treatment, the company provides an educational module to aid in prevention, offering patients insights into their pain management and empowering them with non-pharmacological options.
For healthcare providers, Reducept presents a cost-effective solution, enabling initial treatments with education and the scalability for more comprehensive intervention as necessary. With a focus on expanding their reach and impact in the healthcare sector, this company is poised for growing interest from the investment community.